Neoadjuvant Intraperitoneal Chemotherapy in Patients with Pseudomyxoma Peritonei—A Novel Treatment Approach

Neoadjuvant Intraperitoneal Chemotherapy in Patients with Pseudomyxoma Peritonei—A Novel Treatment Approach

Neoadjuvant intravenous chemotherapy in patients with pseudomyxoma peritonei (PMP) has not shown convincing results. The effectiveness of neoadjuvant intraperitoneal (IP) chemotherapy has never been reported. This prospective, non-randomized phase II study included patients with PMP treated between...

Full description

Bibliographic Details
Main Authors:	Aruna Prabhu, Andreas Brandl, Satoshi Wakama, Shouzou Sako, Haruaki Ishibashi, Akiyoshi Mizumoto, Nobuyuki Takao, Kousuke Noguchi, Shunsuke Motoi, Masumi Ichinose, Yang Liu, Yutaka Yonemura
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	Cancers
Subjects:	pseudomyxoma peritonei neoadjuvant intraperitoneal chemotherapy cytoreductive surgery hyperthermic intraperitoneal chemotherapy pathological response
Online Access:	https://www.mdpi.com/2072-6694/12/8/2212

Similar Items

Progress in Biological Research and Treatment of Pseudomyxoma Peritonei
by: Xi Li, et al.
Published: (2024-04-01)

Hyperthermic intraperitoneal chemotherapy in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei: a 10-year treatment experience in China
by: Bing Wang, et al.
Published: (2024-01-01)

Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
by: Xin Zhao, et al.
Published: (2023-02-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report
by: Ebbe Billmann Thorgersen, et al.
Published: (2018-09-01)

Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept
by: Olivia Sgarbura, et al.
Published: (2020-01-01)

Anesthetic management for cytoreductive surgery of pseudomyxoma peritonei with high intra-abdominal pressure: A case report
by: Yan-Jun Lin, et al.
Published: (2023-01-01)

Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: a propensity score matched study
by: Hayler Raymond, et al.
Published: (2023-03-01)

The Role of Microorganisms in Appendiceal Pseudomyxoma Peritonei: A Review
by: Yekaterina Khamzina, et al.
Published: (2022-05-01)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in a woman with pseudomyxoma peritonei: A case report
by: Clemens B. Tempfer, et al.
Published: (2014-12-01)

Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience
by: Cheng Ernest, et al.
Published: (2023-04-01)

A New Etiology for the Abdominal Compartment Syndrome: Pseudomyxoma Peritonei
by: Charles Sabbagh, et al.
Published: (2015-09-01)

Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers
by: Sebastian Blaj, et al.
Published: (2023-02-01)

Clinicopathological Characteristics and Prognostic Prediction in Pseudomyxoma Peritonei Originating From Mucinous Ovarian Cancer
by: Fengxian Fu, et al.
Published: (2021-04-01)

Retrospective Analysis of Patients with Signet Ring Subtype of Colorectal Cancer with Peritoneal Metastasis Treated with CRS & HIPEC
by: Aruna Prabhu, et al.
Published: (2020-09-01)

Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
by: Kavita Murughan, et al.
Published: (2014-01-01)

A proposal for changing nomenclature from pseudomyxoma peritonei (PMP) to abdomino-peritoneal mucinous carcinoma (APM) based on its long journey and experience from tertiary oncology center in India
by: M. D. Ray, et al.
Published: (2022-06-01)

Effect of standardized fluid management on cardiac function after CRS + HIPEC in patients with PMP: a single-center case-control study
by: Rui Yang, et al.
Published: (2023-12-01)

Long-term survival in patients with PMP: a single-institutional retrospective study from China
by: Rui Yang, et al.
Published: (2023-10-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center
by: Yu HH, et al.
Published: (2017-10-01)

Pressurized intraperitoneal aerosol chemotherapy procedure for nonresectable peritoneal carcinomatosis: First Indian study
by: S P Somashekhar, et al.
Published: (2019-01-01)

Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature review
by: Martín-Román Lorena, et al.
Published: (2023-05-01)

Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience
by: Francesco Santullo, et al.
Published: (2021-08-01)

Drain site enterocutaneous fistula after hyperthermic intraperitoneal chemotherapy
by: Navin Kumar, et al.
Published: (2021-01-01)

Pseudomyxoma Peritonei: A Case Report Diagnosed in a 47-Year-Old Woman with Chronic Pelvic Abdominal Pain and Appendicular Origin: Review of the Literature and Management
by: Francois Pugin, et al.
Published: (2017-12-01)

Epididymitis following Cytoreductive Surgery with Intraperitoneal Oxaliplatin Chemotherapy: Two Case Reports
by: Luiza Damian Ribeiro Barbosa, et al.
Published: (2016-02-01)

Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
by: Jieun Ko, et al.
Published: (2021-09-01)

Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy
by: Hamed Elgendy, et al.
Published: (2019-01-01)

Retrospective Review of Outcomes in Non-Invasive Mucinous Appendiceal Neoplasms with and without Peritoneal Spread: A Cohort Study
by: Arkadii Sipok, et al.
Published: (2022-11-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: our initial experience of implementation and detailed technique
by: Talgat Uskenbayev, et al.
Published: (2019-06-01)

Novel Perspectives in Pseudomyxoma Peritonei Treatment
by: Antonio Sommariva, et al.
Published: (2021-11-01)

Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States
by: Lucia Calthorpe, et al.
Published: (2022-12-01)

A case of Pseudomyxoma Peritonei of an unexpected origin
by: Marie Csanyi-Bastien, et al.
Published: (2021-12-01)

A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
by: Daan R. Löke, et al.
Published: (2020-11-01)

Low-Grade Pseudomyxoma Peritonei Behaving as a High-Grade Disease: A Case Series and Literature Review
by: Petros Bangeas, et al.
Published: (2023-11-01)

The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Maher Al Khaldi, et al.
Published: (2022-11-01)

Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery
by: Hsin-Hsien Yu, et al.
Published: (2023-06-01)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
by: Wei-Chun Chen, et al.
Published: (2022-10-01)

Global trends in research of pseudomyxoma peritonei: a bibliometric and visualization analysis
by: Shuo Liu, et al.
Published: (2024-02-01)

Comparative Survival Outcomes of Hyperthermic Intraperitoneal Chemotherapy, Intraperitoneal Chemotherapy and Intravenous Chemotherapy for Primary Advanced Ovarian Cancer: A Network Meta-Analysis
by: Qin Tang, et al.
Published: (2023-01-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
by: Seung Jae Roh, et al.
Published: (2020-02-01)